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Selection for Immune Responses
to Porcine Circovirus (PCV2) to Decrease
Incidence of Porcine Circovirus Associated Disease
(PCVAD)
Selection for 65-day weight along with PCV2 viremia and antibody titers offers great potential to decrease incidence of PCVAD.
Jared S. Bates
Roman Moreno
Alan R. Doster
Rodger K. Johnson1

Summary
Genetic and environmental effects
on incidence of Porcine Circovirus
Associated Disease (PCVAD) and
immune responses to Porcine Circovirus 2 (PCV2), and their relationships
with body weights were studied in 3,440
pigs of the Nebraska litter size selection lines. Pigs were weighed at birth,
weaning, 65, and 180 days of age and
scored for symptoms of PCVAD every
10 days from 70 to 180 days of age.
Necropsies were performed to conﬁrm
accuracy of scoring. PCV2 viremia, and
antibodies to PCV2, Porcine Reproductive and Respiratory Syndrome Virus,
Mycoplasma hyopneumoniae and
Actinobacillus pleuropneumoniae were
measured in serum from blood samples
drawn at various ages from live pigs
and in tissues of pigs necropsied. PCV2b
genotype was conﬁrmed to be the pathogen causing PCVAD; other pathogens
studied were not involved. Pigs with no
symptoms of PCVAD had signiﬁcantly
greater weights (0.22, 1.12, 6.6, and 46.0
lb, at birth, weaning, 60 d, and 180 d,
respectively) than affected pigs. Heritability of PCVAD score was 16% + 4%.
The location in which pigs were raised
accounted for 22% of the variation
in PCVAD score. Nearly all pigs were
non-viremic until 90 days of age, but
many had antibody titers at weaning
and at 60 days of age. These maternal

antibodies appeared to protect pigs from
PCVAD until approximately 90 days
of age. Heritability of viremia level at
90 days of age was greater than at 125
days of age (38 + 11% vs 11 + 8%).
Genetic variation existed for antibody
titers at 90 (h2 = 55 + 21%) and 125
days of age (h2 = 10 + 8%). Incidence
of PCVAD was correlated genetically
with body weights, PCV2 viremia level,
PCV2 antibody titers, and body weights.
Expected response to direct selection
for reduced PCVAD score was very low
(-0.89% in one generation), whereas
expected response to index selection for
65-day weight and PCV2 viremia and
antibody titers at 90 days of age was
-8.0%, 998% greater than direct selection. Genomic selection for decreased
incidence of PCVAD is feasible.
Introduction
Porcine Circovirus Associated
Disease (PCVAD), caused by Porcine
Circovirus 2 (PCV2), causes high
economic losses to pork producers.
Symptoms of PCVAD in the University
of Nebraska–Lincoln swine research
herd were first observed in 2002. Not
all pigs on the farm were infected and
the incidence rate varied depending on the genetic makeup of the
pigs, their location at the farm, and
season of the year. The incidence rate
in crossbred pigs was very low, but a
significant number of pigs of the UNL
lines selected for increased litter size
were affected. Some pigs seemed to be
highly sensitive to the disease whereas
others in the same pen remained
healthy and showed no symptoms.
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Usually, only one or two pigs in a pen
were affected, but it was common for
a high percentage of pigs within some
litters to be affected, even when raised
in different locations.
These observations pointed to
underlying genetic variation in the
immune response of pigs to the PCV2
virus. A study of PCVAD conducted
at another institution supports this
hypothesis as the incidence rate was
greater in some breed crosses than
others. However, sample size in that
experiment was too small to determine
the degree of genetic variation (heritability) in incidence rate of PCVAD and
in immune responses to PCV2 virus.
If sufficient genetic variation exists,
then greater resistance to PCV2 and
reduced incidence of PCVAD through
selection are possible. When practiced
in nucleus breeding populations,
greater resistance achieved through
selection can be transmitted through
the breeding pyramid to commercial
producers, possibly reducing the need
for vaccination.
We therefore conducted a study in
which pigs were systematically scored
for PCVAD, weighed and bled to create a database for genetic analyses.
Because secondary pathogens are often
thought to be involved in expression
of PCVAD, pigs were also characterized for Porcine Reproductive and
Respiratory Syndrome Virus (PRRVS),
Mycoplasma hyopneumoniae and
Actinobacillus pleuropneumoniae to
determine whether these pathogens
were involved along with PCV2 in
expression of PCVAD.
(Continued on next page)
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Population
Pigs were from generations 24
to 26 of UNL selection lines, Lines
2 and 45, and control lines, Lines 16
and 61, that were derived from a Large
White-Landrace composite population
formed in 1979. Lines 2 and 45 have
been selected for increased litter size
(generations 1 to 20) and increased
litter size, increased growth, and
decreased backfat, generations 21 to
27. Lines 16 and 61 were randomly
selected. Each line is maintained with
40 to 45 litters per generation. Line 2
and 16 litters were born in July and
August (denoted contemporary group
1, CG1) and Line 45 and 61 litters were
born in January and February (CG2).
Pig Management, PCVAD Scoring, and
Serum Sampling
Within two days of farrowing, fostering of pigs among sows both within
and between lines was practiced.
Fostering could not be accomplished
uniformly in all litters. Total number
and number of live pigs per litter, pig
birth (n = 3,440) and weaning weights
(n = 3,438), and number after foster
and weaned per foster dam (NW) were
recorded.
Pigs were weaned at approximately 17 days and grouped by age
in nursery pens of 30 pigs per pen.
At 60-65 days of age, four boars from
each of the 15 largest litters and four to
five females from each of the largest 20
litters in Lines 2 and 45 were identified
as candidates for selection as breeders.
Two sons per sire and one to two gilts
per litter were randomly selected as
candidates for breeding in Lines 16
and 61. Final selections occurred at
180 days of age.
All breeder candidates were placed
in one of six rooms, eight pens per
room and 10 pigs per pen, in a confined, mechanically ventilated building
denoted as Location 1. Remaining pigs
were placed in one of three locations.
Location 2 was a confined building, 25
pens of 10 pigs per pen, with natural
ventilation regulated by thermostatically controlled curtains over windows.
Location 3 was a confined building, 23
pens of 10 pigs per pen, with natural
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ventilation controlled manually by
adjustingdoors over windows. Location 4 was five outdoor lots containing
a small hoop structure with straw
bedding. There were 50 to 60 pigs per
lot. Pigs in CG1 were in Locations 1, 2,
and 3; pigs in CG2 were in Locations
1, 2, and 4.
Pigs with symptoms of PCVAD
were first observed in 2002 (generation
21). Observations in subsequent years
led us to a protocol that produced
data for genetic analyses. During
Generations 24, 25, and 26 pigs were
systematically weighed, scored for
PCVAD, and blood samples were
drawn. Weight at 65 days was recorded
for 2,646 pigs (some pigs were not
weighed) when they were placed in
finishing pens and weight at 180 days
(n = 3,115) were recorded. Beginning 7
days after pigs were placed in finishing
pens, they were scored for symptoms
of PCVAD once every 7 to 10 days,
approximately 10 scores per pig, until
180-day weight was recorded. Pigs
with no symptoms received a score of
0, pig with minor symptoms a score of
1, and pigs with definitive symptoms
a score of 2. Scores were based on
degrees of muscle wasting, growth
retardation, rough hair coat, diarrhea,
and respiratory distress. A score of 1
was used only to identify pigs for more
careful future observation. Only pigs
receiving one or more score of 2 were
considered positive for PCVAD.
Blood was collected at 60, 90, and
125 days of age from all pigs from Generation 25, CG2, and Generation 26,
CGs 1 and 2. Blood was collected from
pigs at weaning in Generation 25, CG2
and from sows in Generation 26, CG1
when their pigs were weaned. PCV2
viremia, a measure of the pigs ability to
replicate virus, was measured in serum
of all pigs with PCVAD score of 2, in
serum from a randomly selected pen
mate with scores of only 0, in samples
of a full sib from another pen, and in
samples from two pigs drawn randomly
from each birth litter in which no pigs
were positive for PCVAD. Serum was
sent to Iowa State University Veterinary
Diagnostic Laboratory, Ames, Iowa,
where Porcine Circovirus II C-ELISA
PCR and PCV2 Quantitation (qPCR)

were performed to obtain PCV2 viremia and antibody levels.
ELISA was used to test subsamples of serum for Mycoplasma
hyopneumoniae (MH), Actinobacillus
pleuropneumoniae (APP), and Porcine
Reproductive and Respiratory Virus
(PRRSV). Samples collected at 90 (n =
261) and 125 days (n = 228) from pigs
from generation 25, CG2, were tested
for MH; samples collected at 125 days
of age from generation 25, CG2 (n
= 228) and Generation 26, CG1 and
CG2 (n = 511) were tested for APP.
The UNL swine herd is free of PRRSV.
To confirm this status, serum from
52 pigs from generations 24 to 26 was
tested for PRRSV.
Necropsies were performed on
samples of pigs with a PCVAD score
of 2 from generation 24, CG1 (n =
10) and CG2 (n = 11), and generation
25, CG2 (n = 17) and in 11 randomly
selected pigs with PCVAD score of 0
from generation 25, CG2. Pigs were
from all locations and only one pig
from any one litter was selected for
necropsy. Immunohistochemistry and
RT-PCR for PCV2 were performed in
lung, cervical lymph node, mesenteric
lymph node, tonsil, kidney, and ileum
of these pigs. Nasal swabs for RT-PCR
testing were collected from five pigs;
two of these pigs had no lesions suggestive of PCVAD. Necropsies and
RT-PCR were done at the Veterinary
Diagnostic Center of the University of
Nebraska Department of Veterinary
and Biomedical Sciences. These pigs
were also tested for PRRSV antibodies
by ELISA. Serum from three pigs that
were necropsied and that were diagnosed with PCVAD were submitted to
the Veterinary Diagnostic Laboratory
at Iowa State University, Ames, Iowa
where Porcine Circovirus II C-ELISA
PCR-PCV2 Quantitation in which the
virus was sequenced to determine the
specific PCV2 transcript in this herd.
Statistical Procedures
Data were analyzed with procedures appropriate for genetic analyses.
Two traits had binomial distributions
as the outcome was either yes or no,
coded as 0 or 1. These were PCVAD
score (1 = positive, 0 = negative) and
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Table 1. Number of observations for each trait by generation and contemporary group.
Generation

Group2

24
24
25
25
26
26

Trait1
BWT

WWT

W65

W180

PCVAD score

669
649
281
511
629
701

669
649
281
510
629
698

—
543
281
510
624
688

659
622
262
431
507
634

669
649
281
511
629
701

Vsows

VW

V60

V90

V125

—
77
—

279
—
—

287
292
—

261
294
217

228
244
211

IgGsows

IgGWIg

G60Ig

G90Ig

G125

—
75
—

280
—
—

287
301
211

271
294
217

229
244
210

1
2
1
2
1
2

25
26
26

2
1
2

25
26
26

2
1
2

1
BWT = birth weight; WWT = weaning weight; W65 = weight at 65 d; W180 = weight at 180 d; Vsows
= sow viremia at weaning; VW = pig viremia at weaning; V60, IgG60, V90, IGg90, V125 and IgG125 =
PCV2 viermia and antibody, respectively, at 60, 90, and 125 days of age.
2
Group1 = Lines 45 and 61 (CG2, winter litters), Group 2 = lines 1 and 2 (CG1, summer litters).

Table 2. Distribution of pigs with combinations of PCVAD score, virema, and IgG levels at days 90
and 125 days within generation (G) and contemporary group (CG) and overall.
PCVAD score1

Viremic2

IgG3

G25CG1

G26CG1

G26CG2Total

Day 90
1
1
1
1
1
1
0
0
0
0
0
0

+
+
+
+
+
+
-

+
S
+
S
+
S
+
S
-

11
48
27
4
11
7
36
55
18
15
19
11

16
64
44
4
3
0
59
68
21
10
5
0

0
0
0
14
8
3
1
0
1
103
57
30

27
112
71
22
22
10
96
123
40
128
81
41

Day 125
1
1
1
1
1
1
0
0
0
0
0
0

+
+
+
+
+
+
-

+
S
+
S
+
S
+
S
-

59
8
3
12
1
0
104
12
0
29
0
0

80
3
0
2
0
0
145
3
0
11
0
0

9
3
0
0
1
4
78
17
12
13
19
55

148
14
3
14
2
4
327
32
12
53
19
55

1

0 = negative and 1 = positive score for PCVAD.
+ indicates PCV2 viremia level > 0, - indicates PCV2 viremia = 0.
3
+ = IgG titer ≥ 0.5, S = 0.2 < titer < 0.5, - = titer < 0.2.
2

whether a pig was viremic (0 = no
viral replication, 1 = viral replication,
veremia level greater than 0). For those
pigs that were viremic (coded score
of 1) the observed viremia (genomic
copies per ml) were expressed as log10
to normalize the distribution. PCV2
antibody titers and body weights were
normally distributed.
Table 1 contains a description of
traits and numbers of records. Table 2
contains the joint distributions of PCVAD scores, PCV2 viremia, and PCV2
antibody titers. Genetic analyses used a
pedigree file containing 12,032 pigs, all
those with phenotypes in the present
study and all parent animals tracing
back to the base generation. Traits analyzed were PCVAD Score, birth weight,
weaning weight, 65-day weight, 180-day
weight, viremia scores at 90 days and
125 of age (the 0 or 1 code), log10 of
viremia level at 90 days and 125 days of
age in pigs with positive viremia scores,
and PCV2 antibody titers at 60, 90, and
125 days of age. Antibody titers .5 and
greater are considered to be positive,
evidence that the pig had been exposed
to virus, titers of .2 to .49 are in the
suspect range, and those below .2 are
considered to be negative.
Results
Observations and Fixed Effects
Overall, 14.4% of pigs had at least
one positive PCVAD score, but the
incidence varied greatly across generations (Figure 1). Mortality rate of pigs
with positive score was 35.4%. Genetic
lines did not differ significantly in incidence of PCVAD.
Nearly all serum samples collected
at 60 days of age (94.6 %) were negative for PCV2 viremia; therefore viremia at 60 days of age was not analyzed.
All but two serum samples collected at
90 days of age from pigs in generation
26, CG2 had negative viremia (Table
2); therefore, data from that group
were deleted from analyses of 90-day
viremia level. All but two serum samples collected from weaned pigs were
negative for PCV2 viremia, but 37
of 77 of their dams were positive.
Average antibody titers for sows and
(Continued on next page)

© The Board of Regents of the University of Nebraska. All rights reserved.

2009 Nebraska Swine Report — Page 35

progeny were 1.07 + 0.15 and
0.90 + 0.16, respectively.
Antibody titers for PCV2 at 60,
90, and 125 days of age for each contemporary group are shown in Figure
2. Titers at 60 and 90 days were similar
in generation 25, CG2, and generation
26, CG1, greatest in Generation 26.
Frequency of viremic pigs varied
greatly across generations, contemporary groups, and ages (Figure 3). In
generation 26, CG2, 53.9% of the pigs
were non-viremic at 90 days of age
but had antibody titers greater than
0.5 (Table 2). Only 5.9% of the pigs in
other groups were non-viremic and had
high antibody titers. Non-viremic pigs
at 125 days of age with antibody titers
less than 0.2 occurred in 60.8% of pigs
from generation 26 CG2, but in only
10.2% of the pigs in the other groups.
Incidence of PCVAD was greater
in males than females and males had
greater (P < 0.05) PCV2 antibody
titers at 60 (0.03) and 90 days (0.05).
The probability of being viremic at 90
days of age was less for females than
males (-0.30, P < 0.05).
Pigs with 0 PCVAD score weighed
more (P < 0.0001) at birth, weaning,
65 d, and 180 days (0.22, 1.12, 6.6, and
46.0 lb, respectively) than pigs with
score of 1. They also had lower PCV2
viremia levels at 90 (0.26 +0.15) and
125 days (0.85 + 0.12) and greater
antibodytiters (0.04 + 0.01 and
0.05 + 0.02, respectively).
PCV2 Sequence
All three pigs whose PCV2
mRNA was sequenced were positive
for PCV2b genotype. The sequence
for one pig was 100% identical to a
PCV2 isolate previously characterized
and described in the National Center
for Biotechnology Information database. The sequences for the other two
pigs were not 100% identical to any
sequencein the database. One of them
had a single base change at position
116 (G to A); the other one had two
base changes, one at position 116 (G
to A) and one at position 465 (C to G).
These findings confirm that PCV2b
was the causative virus for PCVAD in
this population but that mutations
2009 Nebraska Swine Report — Page 36

25
20
15

Gen 24

10

Gen 25

5

Gen 26

0

Line 2

Line 16

Line 45

Line 61

Figure 1. Percentage of pigs scored positive for PCVAD.

1
0.8
0.6

Gen 25, CG2

0.4

Gen 26, CG1

0.2

Gen 26, CG2

0
60 days

90 days

125 days

Figure 2. Mean PCV2 antibody titers.

100
80
60
90 days
40

125 days

20
0
Gen 25, CG2

Gen 26, CG1

Gen, CG2

Overall

Figure 3. Viremic pigs, %, at 90 and 125 days.

had occurred causing slightly different
nucleotide sequences from those previously characterized.
Necropsy Findings.
Tissue samples from 36 of the
38 pigs that were positive for PCVAD
were also positive for PCV2. Tissues of the other two were negative,
but their nasal swabs were positive.
Tissuesfrom all 11 pigs scored as
negative for PCVAD were negative for

PCV2. Pigs with PCVAD had severe
wasting, weight loss, rough hair coat,
enlarged mesenteric lymph nodes,
lesions indicativeof pneumonia, and
chronic colitis. Lymphocyte depletion within mesenteric lymph nodes
and giant cells in lymphoid follicles,
splenic follicles, and Peyer’s Patches,
and thymic atrophy due to lymphocyte
depletion were observed. Nineteen
pigs had symptoms of Mycoplasma
hyopneumoniae; 18 had symptoms of
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Table 3. Percentage of variation in PCVAD score and body weights due to different sources.
PCVAD
score

Source1
Pigs genes (hd2)
Dam’s genes (hm2)

10.0
27.5
11.2
22.0
5.1
47.2

Phenotypic standard
deviation
2

WWT, lb

Genetic effects
26.7 +7.0
16.0 +6.0
18.3
Environmental effects
11.0
12.0
1.0
0.2
3.0
5.0
43.3
57.1

16.0+ 4.0

Birth litter
Weaning litter
Contemporary group
Location
Pen
Residual

1

BWT, lb

1.46
2

hd = direct heritability, hm

0.11

65-day wt, lb

180-day wt, lb

23.0 + 6.02

3.0 + 6.0
11.0

8.0

7.0

47.0

51.0

0.43

1.97

6.4
2

=

maternal heritability (+ standard error of estimate of hd ).

Table 4. Percentage of variance of PCV2 viremia score1, vermia level2, and antibody titers3 at 90 and
125 days of age.1
Parameter4

VS90

VS125

5.0
77.0
2.0

4.9

2

Pigs genes (hd )
Birth litter
Contemporary group
Location
Room
Residual
σp2

Viremia90 Viremia125
38 + 11

15.0
2.57

24.0
26.2
44.9
1.50

11 + 8
18.0
2.1

1.9
60.2
1.5

IgG90

68.4
0.97

33.3
16.7

50.0
0.24

IgG902

IgG125

55 + 21
7.5

10 + 8
5.6
18.9
33.3
6.7
25.6
0.3

37.5
0.2

1

VS90 and VS125 = viremia score (positive vs 0).
Viremia90 and Viremia125 = log10 (PCV2 genomic copies/mL) for pigs with positive scores.
3
IgG90 and IgG125 = PCV2 antibody titer.
2
Generation 26, CG2 data deleted.
4 2
hd = direct heritability + standard error.
2

Streptococcus suis, and four had symptoms of Lawsonia intracellularis.
ELISA Screening
All serum samples tested for
PRRSV and for Mycoplasma hyopneumoniae were negative. Thirty two of
the 228 serum samples collected at 125
days of age from generation 25, CG2
pigs were positive for APP. Twenty one
of 513 serum samples collected at 90
days of age from pigs of generation 26
were positive for APP, 16 had titers in
the suspect range, and the rest were
negative. Eight pigs that were positive for APP and five with titers in the
suspect range had positive PCVAD
scores. However, 142 pigs with positive PCVAD scores were negative for
APP. Thus, PRRSV and Mycoplasma
hyopneumoniae can be ruled out as
secondary pathogens, and APP was not
likely a secondary pathogen, involved
in expression of PCVAD in this population.

Genetic and Environmental Parameters
Percentages of total variation due
to genetic and environmental effects
for PCVAD score and body weights
are in Table 3 and those for PCV2
viremia and antibody titers are in
Table 4. Direct heritability, a measure
of the relative importance of genes
of the pig, of PCVAD score was 16
+ 4%. Heritabilities of body weights
ranged from 16% for weaning weight
to 27% for birth weight. Genes of
the dam, maternal heritability, were
important for birth and 180-day
weights. The location in which pigs
were raised accounted for the most
variation (22%) in PCVAD score
whereas several environmental sources
of variation contributed to variation
in body weights. For pigs with positive
viremia score (levels greater than zero),
heritability estimate of viremia level at
90 days of age was greater than at 125
days of age (38 + 11% vs 11 + 8%).
Genetic variation existed for antibody
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titers at 125 days of age (h2 = 10 +
8%), but not at 90 days of age when
all data were included in analyses.
However, when data for generation 26,
CG2 were deleted, genetic variation
in PCV2 antibody titer at 90 days of
age was high (h2 = 55 + 21%). A large
percentage of the variation in viremia
score at 90 and 125 days of age was due
to either the location or the room in
which pigs were raised. These sources
of variation were relatively small for
viremia level and antibody titers.
Genetic and residual correlations
among traits were calculated but are
not presented here. The important
ones were that PCVAD score was quite
highly correlated genetically with day
90 viremia (rg = 0.75) and antibody
level (rg = -0.67) and moderately correlated with 65-day weight (rg = -0.53).
Neither birth weight nor weaning
weight were significantly correlated
genetically with viremia or antibody
levels. However, weaning weight was
highly correlated genetically with viremia at 125 days of age (rg = -0.73) and
180-day weight was negatively correlated with viremia at both 90 and 125
days of age and positively correlated
with antibody titers at 90 days of age.
Viremia level at 90 and 125 days of age
were positively correlated genetically
(rg = 0.59) and viremia and antibody
titers at 90 days of age were negatively
correlated (rg = -0.51). Antibody titers
at 90 and 125 days of age were positively correlated (rg = 0.59).
Although several environmental
correlations among traits were significant, none were especially strong. Most
notable were that environmental effects
on score for PCVAD and for body
weights through 65 days of age were
correlated (-0.47 < re < -0.39), environmental effects on viremia and antibody
levels at 90 days of age were correlated
(re = -0.38), and viremia at 90 days of
age was negatively correlated with body
weights (-0.26 < re < -0.16).
Discussion
We conclude from this study and
others in the literature that genetic
variation in incidence of PCVAD
(Continued on next page)
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and measures of immune responses
to PCV2 exists. The heritability of
PCVAD score was 16% and heritabilities of PCV2 viremia and antibody
levels at 90 days of age were 38% and
55%, respectively. Genetic variation
in viremia and antibody levels at 125
days of age were less and were not significant, perhaps because death of pigs
with PCVAD between 90 and 125 days
resulted in fewer records and decreased
the genetic variance in remaining pigs.
Viremia and antibody levels at 90
days of age and 65-day weight were
quite highly correlated genetically with
PCVAD score. Thus selection for these
traits may be an effective way to decrease incidence of PCVAD. Expected
selection responses were calculated
for different selection strategies. These
were 1) direct selection — selection of
breeders only from pigs that never displayed symptoms of PCVAD, 2) singletrait selection for weight, viremia, or
antibody levels, and 3) index selection
for correlated traits or PCVAD score
plus correlated traits.
Even though PCVAD score is
heritable, direct selection was relatively
ineffective, resulting in a reduction
of incidence of PCVAD of only -.8%
in the first generation. This result occurred because 85% of the pigs, those
with score of 0, were candidates for
selection, resulting in a very low selection rate. The other traits are continuously distributed so pigs vary across
the entire range of the distribution.
Assuming 10% of the males and 30%
of the females are selected for high
PCV2 antibody titers at 90 days resulted in the greatest correlated expected
response to single-trait selection (generation 1 response = -6.5%). Greatest
expected response was for a three-trait
index including 65-day weight and
PCV2 viremia and antibody titers at
90 days of age (-8.0%). A four-trait
index of these traits and PCVAD score
produced the same expected response
per generation. Expected selection
responses were 414 to 998% greater
when correlated traits were used than
from direct selection.
Necropsy results confirmed that
PCV2 was the main causative agent
of PCVAD in this population. Geno2009 Nebraska Swine Report — Page 38

typing PCV2 revealed that PCV2b was
likely the causative agent. However, at
least three allelic forms, and possibly
more, existed. Thus, mutations have
occurred in the PCV2b genome, but
the consequence is not known.
Porcine Reproductive and
Respiratory Virus, Mycoplasma
hyopneumoniae, and Actinobacillus
pleuropneumoniae were not secondary
pathogens involved in expression of
PCVAD. In other work, co-infection
of pigs with PCV2 and Gram-negative
bacteria induced viral replication of
PCV2. Diagnostics for these pathogens
were not performed, but infection of
pigs with pathogens such as Escherichia coli and Haemophilus inﬂuenzae,
Gram-negative bacteria known to be
present in this population, may have
increased the risk of PCVAD.
A strong relationship between
PCV2 viremia level at 90 days of age
and incidence of PCVAD across contemporary groups existed. Incidence
of positive PCVAD Scores was 3.9%
in generation 26, CG2, and only 1%
of these pigs were viremic at 90 days
of age. The incidences of PCVAD in
generation 25, CG2, and Generation
26, CG1, were greater than 20%; 75%
and 93% of the pigs in these respective
groups were viremic.
Pigs with PCVAD differed in birth
weight, weaning weight, 65-day weight,
and 180-day weight, even though some
of these weights were recorded well
before pigs expressed symptoms of
PCVAD. The genetic correlations of
PCVAD score with birth and weaning
weights were positive, but not significant. However, environmental correlations were negative and significant,
indicating that the phenotypic relationship was largely due to environmental effects that reduced early body
weights and increased risk of PCVAD.
Mean PCV2 antibody titers in pigs
at weaning was high, most likely due to
maternal PCV2 antibodies because all
these pigs were non-viremic. Antibody
titers decreased from weaning to 60
days of age, but 94.6% of pigs were
still non-viremic at 60 days of age.
Antibody titers continued to decrease
from 60 to 90 days of age, suggesting that maternal antibodies were

deteriorating. Effects associated with
the birth litter were a major source
of variation in antibody titers at 60
and 90 days of age, providing further
evidence for significant variation associated with maternal antibodies. Other
work has shown that high titers of
maternal PCV2 antibodies are generally protective against PCV2, whereas
low titers are not; however, maternal
antibodies do not fully prevent PCV2
infections. Thus, pigs in our study
were likely at least partially protected
from PCV2 by maternal antibodies to
at least 60 days of age.
Implications
Immune responses to PCV2 are
heritable. Thus, genetic selection could
be a useful tool to reduce incidence
of PCVAD. Even though progress is
permanent, several generations of
selection will be required to greatly
reduce the incidence and this selection
must be practiced in nucleus herds and
then transmitted through the breeding
pyramid to commercial populations.
Consequently, it would take considerable time for such a strategy to significantly reduce the incidence of PCVAD
in commercial herds. Furthermore,
response to selection for PCVAD
scores, viremia, and antibody levels
will occur only if all pigs in nucleus
populations are exposed to PCV2 so
that variation reﬂects genetic variation in the traits. Marker assisted or
genomic selection may be more effective as once marker panels with known
relationships with response variables
are available, selection can be practiced
in any population without exposure of
pigs to PCV2. Thus genomic selection
for resistance to PCV2 and decreased
incidence of PCVAD may be the most
effective long term selection strategy.
1

Jared S. Bates was a graduate student,
Roman Moreno is a graduate student and
research technologist in the Animal Science
Department; Alan R. Doster is a professor in
the Department of Veterinary and Biomedical
Science; and Rodger K. Johnson is a professor in
the Animal Science Department.

© The Board of Regents of the University of Nebraska. All rights reserved.

